Literature DB >> 23958593

RBPJ is disrupted in a case of proximal 4p deletion syndrome with epilepsy.

Tojo Nakayama1, Hirotomo Saitsu2, Wakaba Endo3, Atsuo Kikuchi4, Mitsugu Uematsu4, Kazuhiro Haginoya3, Naomi Hino-fukuyo4, Tomoko Kobayashi4, Masaki Iwasaki5, Teiji Tominaga5, Shigeo Kure4, Naomichi Matsumoto2.   

Abstract

Proximal 4p deletion syndrome is characterized clinically by mental retardation, minor dysmorphic facial features, and is occasionally complicated with epilepsy. More than 20 cases of proximal 4p deletion syndrome have been reported, but the causative gene(s) remain elusive. We describe here a 2-year-old female patient with a common manifestation of proximal 4p deletion syndrome and infantile epileptic encephalopathy possessing a de novo balanced translocation t(4;13)(p15.2;q12.13). The patient was diagnosed as infantile spasms at 9 months of age. She presented with dysmorphic facial features and global developmental delay, compatible with proximal 4p deletion syndrome. Using fluorescence in situ hybridization, we determined the translocation breakpoint at 4p15.2 to be within RBPJ. RBPJ is a transcription factor in the Notch/RBPJ signaling pathway, playing a crucial role in the developing human brain, and particularly telencephalon development. Our findings, combined with those of previous studies, strongly suggest that RBPJ is causative for proximal 4p deletion syndrome and epilepsy in this case.
Copyright © 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Balanced translocation; Infantile spasms; Proximal 4p deletion syndrome; RBPJ

Mesh:

Substances:

Year:  2013        PMID: 23958593     DOI: 10.1016/j.braindev.2013.07.009

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  1 in total

Review 1.  Post-Developmental Roles of Notch Signaling in the Nervous System.

Authors:  Jose L Salazar; Sheng-An Yang; Shinya Yamamoto
Journal:  Biomolecules       Date:  2020-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.